The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Nuclear export of proteins and drug resistance in cancer
Open accessAbstract
The intracellular location of a protein is crucial to its normal functioning in a cell. Cancer cells utilize the normal processes of nuclear-cytoplasmic transport through the nuclear pore complex of a cell to effectively evade anti-neoplastic mechanisms. CRM1-mediated export is increased in various cancers. Proteins that are exported in cancer include tumor-suppressive proteins such as retinoblastoma, APC, p53, BRAC1, FOXO proteins, INI1/hSNF5, galectin-3, Bok, nucleophosmin, RASSF2, Merlin, p21CIP, p27KIP1, N-WASP/FAK, estradiol receptor and Tob, drug targets topoisomerase I and IIα and BCR-ABL, and the molecular chaperone protein Hsp90. Here, we review in detail the current processes and known structures involved in the export of a protein through the nuclear pore complex. We also discuss the export receptor molecule CRM1 and its binding to the leucine-rich nuclear export signal of the cargo protein and the formation of a nuclear export trimer with RanGTP. The therapeutic potential of various CRM1 inhibitors will be addressed, including leptomycin B, ratjadone, KOS-2464, and specific small molecule inhibitors of CRM1, N-azolylacrylate analogs, FOXO export inhibitors, valtrate, acetoxychavicol acetate, CBS9106, and SINE inhibitors. We will also discuss examples of how drug resistance may be reversed by targeting the exported proteins topoisomerase IIα, BCR-ABL, and galectin-3. As effective and less toxic CRM1 export inhibitors become available, they may be used as both single agents and in combination with current chemotherapeutic drugs. We believe that the future development of low-toxicity, small-molecule CRM1 inhibitors may provide a new approach to treating cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
Cellular roles of DNA topoisomerases: a molecular perspective
Wang, J. C. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm831 · Cited by 2,353
BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER
Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I., & Gottesman, M. M. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.361 · Cited by 2,059
Signals for Sorting of Transmembrane Proteins to Endosomes and Lysosomes
Bonifacino, J. S., & Traub, L. M. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161800 · Cited by 2,040
APC mutations occur early during colorectal tumorigenesis
Powell, S. M., Zilz, N., Beazer-Barclay, Y., Bryan, T. M., Hamilton, S. R., Thibodeau, S. N., Vogelstein, B., & Kinzler, K. W. (1992) · Nature · doi:10.1038/359235a0 · Cited by 1,924
A C-terminal signal prevents secretion of luminal ER proteins
Munro, S., & Pelham, H. R. B. (1987) · Cell · doi:10.1016/0092-8674(87)90086-9 · Cited by 1,721
Molecular mechanisms of drug resistance
Longley, D., & Johnston, P. (2005) · The Journal of Pathology · doi:10.1002/path.1706 · Cited by 1,672
Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis
Welsh, M. J., & Smith, A. E. (1993) · Cell · doi:10.1016/0092-8674(93)90353-r · Cited by 1,485
The Yeast Nuclear Pore Complex
Rout, M. P., Aitchison, J. D., Suprapto, A., Hjertaas, K., Zhao, Y., & Chait, B. T. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.4.635 · Cited by 1,400
Classical Nuclear Localization Signals: Definition, Function, and Interaction with Importin α
Lange, A., Mills, R. E., Lange, C. J., Stewart, M., Devine, S. E., & Corbett, A. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r600026200 · Cited by 1,146
Zhou, B. P., Liao, Y., Xia, W., Spohn, B., Lee, M.-H., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/35060032 · Cited by 1,135
A conserved tripeptide sorts proteins to peroxisomes.
Gould, S. J., Keller, G. A., Hosken, N., Wilkinson, J., & Subramani, S. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.5.1657 · Cited by 1,106
Kudo, N., Matsumori, N., Taoka, H., Fujiwara, D., Schreiner, E. P., Wolff, B., Yoshida, M., & Horinouchi, S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9112 · Cited by 1,029
Multidrug resistance (MDR) in cancer
Krishna, R., & Mayer, L. D. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00114-7 · Cited by 1,026
Thomas, H., & Coley, H. M. (2003) · Cancer Control · doi:10.1177/107327480301000207 · Cited by 931
Environment-mediated drug resistance: A major contributor to minimal residual disease
Meads, M. B., Gatenby, R. A., & Dalton, W. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2714 · Cited by 892
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia
Ren, R. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1567 · Cited by 878
Stommel, J. M., Marchenko, N. D., Jimenez, G. S., Moll, U. M., Hope, T. J., & Wahl, G. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1660 · Cited by 738
Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death
Perillo, N. L., Marcus, M. E., & Baum, L. G. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050232 · Cited by 640
Apoptosis inhibitory activity of cytoplasmic p21Cip1/WAF1 in monocytic differentiation
Asada, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1223 · Cited by 586
Dumontet, C., & Sikic, B. I. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.1061 · Cited by 574
Anandatheerthavarada, H. K., Biswas, G., Robin, M.-A., & Avadhani, N. G. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207030 · Cited by 571 · cited 1×
“In addition, amino acid signaling sequences govern protein trafficking to the endoplasmic reticulum [35,36], Golgi apparatus [37], lysosomes [38], mitochondria [39], and peroxisomes [40].”
BackgroundNakamura, N., Ramaswamy, S., Vazquez, F., Signoretti, S., Loda, M., & Sellers, W. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8969-8982.2000 · Cited by 570
Skorski, T., Bellacosa, A., Nieborowska‐Skorska, M., Majewski, M., Martinez, R., Choi, J. K., Trotta, R., Wlodarski, P., Perrotti, D., Chan, T. O., et al. (1997) · The EMBO Journal · doi:10.1093/emboj/16.20.6151 · Cited by 567
Matsuyama, A., Arai, R., Yashiroda, Y., Shirai, A., Kamata, A., Sekido, S., Kobayashi, Y., Hashimoto, A., Hamamoto, M., Hiraoka, Y., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1222 · Cited by 560
Rules for Nuclear Localization Sequence Recognition by Karyopherinβ2
Lee, B. J., Cansizoglu, A. E., Süel, K. E., Louis, T. H., Zhang, Z., & Chook, Y. M. (2006) · Cell · doi:10.1016/j.cell.2006.05.049 · Cited by 555
Crossing the Nuclear Envelope: Hierarchical Regulation of Nucleocytoplasmic Transport
Terry, L. J., Shows, E. B., & Wente, S. R. (2007) · Science · doi:10.1126/science.1142204 · Cited by 548
Ishikawa, T., & Ali-Osman, F. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80702-9 · Cited by 533
Structural Biology of Nucleocytoplasmic Transport
Cook, A., Bono, F., Jinek, M., & Conti, E. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.052705.161529 · Cited by 525
Reichelt, R., Holzenburg, A., Buhle, E. L., Jarnik, M., Engel, A., & Aebi, U. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.4.883 · Cited by 508
Nuclear transport and cancer: from mechanism to intervention
Kau, T. R., Way, J. C., & Silver, P. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1274 · Cited by 468
The role of DNA mismatch repair in drug resistance
Nebel, S. (1998) · ETH Zürich Research Collection · doi:10.3929/ethz-a-001915508 · Cited by 461
Dabholkar, M., Vionnet, J., Bostick-Bruton, F., Yu, J. J., & Reed, E. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117388 · Cited by 446
Honjo, Y., Hrycyna, C. A., Yan, Q. W., Medina-Pérez, W. Y., Robey, R. W., van de Laar, A., Litman, T., Dean, M. C., & Bates, S. E. (2001) · PubMed · Cited by 429
Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity.
Xu, Y., & Villalona-Calero, M. A. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf337 · Cited by 413
The role of DNA mismatch repair in drug resistance.
Fink, D. A., Aebi, S. P., & Howell, S. B. (1998) · PubMed · Cited by 410
Henderson, B. R., & Eleftheriou, A. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4825 · Cited by 387
A p53 Amino-Terminal Nuclear Export Signal Inhibited by DNA Damage-Induced Phosphorylation
Zhang, Y., & Xiong, Y. (2001) · Science · doi:10.1126/science.1058637 · Cited by 378
Regulation of Nuclear Transport: Central Role in Development and Transformation?
Poon, I. K. H., & Jans, D. A. (2005) · Traffic · doi:10.1111/j.1600-0854.2005.00268.x · Cited by 360
Nikolaev, A. Y., Li, M., Puskas, N., Qin, J., & Gu, W. (2003) · Cell · doi:10.1016/s0092-8674(02)01255-2 · Cited by 356
Bogerd, H. P., Fridell, R. A., Benson, R. E., Hua, J., & Cullen, B. R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4207 · Cited by 351
Dissection of a Nuclear Localization Signal
Hodel, M. R., Corbett, A. H., & Hodel, A. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008522200 · Cited by 334
Interaction of tumor cells with the microenvironment
Ungefroren, H., Sebens, S., Seidl, D., Lehnert, H., & Hass, R. (2011) · Cell Communication and Signaling · doi:10.1186/1478-811x-9-18 · Cited by 333
Vigneri, P., & Wang, J. Y. J. (2001) · Nature Medicine · doi:10.1038/84683 · Cited by 331
Structural basis for leucine-rich nuclear export signal recognition by CRM1
Dong, X., Biswas, A., Süel, K. E., Jackson, L. K., Martinez, R., Gu, H., & Chook, Y. M. (2009) · Nature · doi:10.1038/nature07975 · Cited by 330
Kau, T. R., Schroeder, F., Ramaswamy, S., Wojciechowski, C. L., Zhao, J. J., Roberts, T. M., Clardy, J., Sellers, W. R., & Silver, P. A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00303-9 · Cited by 329
Leucine-rich nuclear-export signals: born to be weak
Kutay, U., & Güttinger, S. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.01.005 · Cited by 327
Triple Layer Control: Phosphorylation, Acetylation and Ubiquitination of FOXO Proteins
Vogt, P. K., Jiang, H., & Aoki, M. (2005) · Cell Cycle · doi:10.4161/cc.4.7.1796 · Cited by 295
Nuclear Localization and Export Signals of the Human Aryl Hydrocarbon Receptor
Ikuta, T., Eguchi, H., Tachibana, T., Yoneda, Y., & Kawajiri, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2895 · Cited by 287
Phosphorylation of p27 on Serine 10 Is Required for Its Binding to CRM1 and Nuclear Export
Ishida, N., Hara, T., Kamura, T., Yoshida, M., Nakayama, K., & Nakayama, K. I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100762200 · Cited by 264
van der Watt, P. J., Maske, C. P., Hendricks, D. T., Parker, M. I., Denny, L., Govender, D., Birrer, M. J., & Leaner, V. D. (2009) · International Journal of Cancer · doi:10.1002/ijc.24146 · Cited by 250
Newlands, E., Rustin, G., & Brampton, M. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.415 · Cited by 248
Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties
Matarrese, P., Fusco, O., Tinari, N., Natoli, C., Liu, F.-T., Semeraro, M. L., Malorni, W., & Iacobelli, S. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000215)85:4<545::aid-ijc17>3.0.co;2-n · Cited by 244
Galectin-3 as a multifunctional protein.
Krześlak, A., & Lipińska, A. (2004) · PubMed · Cited by 238
Crystal Structure of the Nuclear Export Receptor CRM1 in Complex with Snurportin1 and RanGTP
Monecke, T., Güttler, T., Neumann, P., Dickmanns, A., Görlich, D., & Ficner, R. (2009) · Science · doi:10.1126/science.1173388 · Cited by 237
Regulation of tumor suppressors by nuclear-cytoplasmic shuttling
Fabbro, M., & Henderson, B. R. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00019-8 · Cited by 231
Lotz, M. M., Andrews, C. W., Korzelius, C. A., Lee, E. C., Steele, G. D., Clarke, A., & Mercurio, A. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3466 · Cited by 230
Boyer, J., McLean, E. G., Aroori, S., Wilson, P., McCulla, A., Carey, P. D., Longley, D. B., & Johnston, P. G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0362 · Cited by 229
Takenaka, Y., Fukumori, T., Yoshii, T., Oka, N., Inohara, H., Kim, H.-R. C., Bresalier, R. S., & Raz, A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.10.4395-4406.2004 · Cited by 228
Kavallaris, M., Tait, A., Walsh, B. J., He, L., Horwitz, S. B., Norris, M. D., & Haber, M. (2001) · PubMed · Cited by 221
Ran‐dependent nuclear export mediators: a structural perspective
Güttler, T., & Görlich, D. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.287 · Cited by 221
Noske, A., Weichert, W., Niesporek, S., Röske, A., Buckendahl, A., Koch, I., Sehouli, J., Dietel, M., & Denkert, C. (2008) · Cancer · doi:10.1002/cncr.23354 · Cited by 218
The importance of p53 location: nuclear or cytoplasmic zip code?
O’Brate, A., & Giannakakou, P. (2003) · Drug Resistance Updates · doi:10.1016/j.drup.2003.10.004 · Cited by 208
Hazlehurst, L. A., Landowski, T. H., & Dalton, W. S. (2003) · Oncogene · doi:10.1038/sj.onc.1206943 · Cited by 203
Association of galectin-1 and galectin-3 with Gemin4 in complexes containing the SMN protein
Park, J. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.17.3595 · Cited by 198
Recognition of nuclear targeting signals by Karyopherin-β proteins
Xu, D., Farmer, A., & Chook, Y. M. (2010) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2010.09.008 · Cited by 197
Identification of Nuclear Export Inhibitors with Potent Anticancer Activity In vivo
Mutka, S. C., Yang, W. Q., Dong, S. D., Ward, S. L., Craig, D. A., Timmermans, P. B. M. W. M., & Murli, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-0858 · Cited by 195
Ubiquitin‐Related Modifier SUMO1 and Nucleocytoplasmic Transport
Pichler, A., & Melchior, F. (2002) · Traffic · doi:10.1034/j.1600-0854.2002.30601.x · Cited by 194
Crm1 is a mitotic effector of Ran-GTP in somatic cells
Arnaoutov, A., Azuma, Y., Ribbeck, K., Joseph, J., Boyarchuk, Y., Karpova, T., McNally, J., & Dasso, M. (2005) · Nature Cell Biology · doi:10.1038/ncb1263 · Cited by 191
Connor, M. K., Kotchetkov, R., Cariou, S., Resch, A., Lupetti, R., Beniston, R. G., Melchior, F., Hengst, L., & Slingerland, J. M. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-06-0319 · Cited by 182
Nuclear export of the APC tumour suppressor controls β-catenin function in transcription
Rosin-Arbesfeld, R., Cliffe, A., Brabletz, T., & Bienz, M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg105 · Cited by 179
Dynamics of galectin-3 in the nucleus and cytoplasm
Haudek, K. C., Spronk, K. J., Voss, P. G., Patterson, R. J., Wang, J. L., & Arnoys, E. J. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.07.005 · Cited by 177
EXPRESSION OF CRM1 IN HUMAN GLIOMAS AND ITS SIGNIFICANCE IN P27 EXPRESSION AND CLINICAL PROGNOSIS
Shen, A., Wang, Y., Zhao, Y., Zou, L., Sun, L., & Cheng, C. (2009) · Neurosurgery · doi:10.1227/01.neu.0000348550.47441.4b · Cited by 173
Wadhwa, R. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5468 · Cited by 170
Prognostic value of CRM1in pancreas cancer
Huang, W.-Y., Yue, L., Qiu, W.-S., Wang, L.-W., Zhou, X.-H., & Sun, Y.-J. (2009) · Clinical and Investigative Medicine · doi:10.25011/cim.v32i6.10668 · Cited by 170
CRM1-Mediated Nuclear Export of Proteins and Drug Resistance in Cancer
Turner, J., & Sullivan, D. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708786242859 · Cited by 169
Self-citationDown-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells.
Honjo, Y., Nangia‐Makker, P., Inohara, H., & Raz, A. (2001) · PubMed · Cited by 163
Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives
Roe, M., Folkes, A., Ashworth, P., Brumwell, J., Chima, L., Hunjan, S., Pretswell, I., Dangerfield, W., Ryder, H., & Charlton, P. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00030-x · Cited by 163
Neufeld, K. L., Nix, D. A., Bogerd, H., Kang, Y., Beckerle, M. C., Cullen, B. R., & White, R. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220401797 · Cited by 160
Karpa, K. D., Lin, R., Kabbani, N., & Levenson, R. G. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.4.677 · Cited by 160
Nucleocytoplasmic Transport: Navigating the Channel
Bednenko, J., Cingolani, G., & Gerace, L. (2003) · Traffic · doi:10.1034/j.1600-0854.2003.00109.x · Cited by 159
Joo, H., Goedegebuure, P. S., Sadanaga, N., Nagoshi, M., von Bernstorff, W., & Eberlein, T. J. (2001) · PubMed · Cited by 159
Identification of a Functional Nuclear Export Sequence in BRCA1
Rodríguez, J. A., & Henderson, B. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003851200 · Cited by 153
The expression of CRM1 is associated with prognosis in human osteosarcoma
Yao, Y. (1994) · Oncology Reports · doi:10.3892/or_00000213 · Cited by 153
Robinson, M. J., & Osheroff, N. (1991) · Biochemistry · doi:10.1021/bi00221a012 · Cited by 147
Sanchez, A. M., Flamini, M. I., Baldacci, C., Goglia, L., Genazzani, A. R., & Simoncini, T. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0252 · Cited by 134
Endogenous Galectin-3 Determines the Routing of CD95 Apoptotic Signaling Pathways
Fukumori, T., Takenaka, Y., Oka, N., Yoshii, T., Hogan, V. A., Inohara, H., Kanayama, H.-O., Kim, H.-R. C., & Raz, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0336 · Cited by 134
Nucleolar NF-κB/RelA mediates apoptosis by causing cytoplasmic relocalization of nucleophosmin
Khandelwal, N., Simpson, J., Taylor, G., Rafique, S., Whitehouse, A., Hiscox, J. A., & Stark, L. A. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.79 · Cited by 133
Expression and function of galectin-3, a β-galactoside-binding protein in activated T lymphocytes
Joo, H., Goedegebuure, P. S., Sadanaga, N., Nagoshi, M., von Bernstorff, W., & Eberlein, T. J. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.4.555 · Cited by 130
Leptomycins A and B, new antifungal antibiotics. II. Structure elucidation.
Hamamoto, T., Seto, H., & Beppu, T. (1983) · The Journal of Antibiotics · doi:10.7164/antibiotics.36.646 · Cited by 127
A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export
Daelemans, D., Afonina, E., Nilsson, J., Werner, G., Kjems, J., Clercq, E. D., Pavlakis, G. N., & Vandamme, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212285299 · Cited by 126
Towards reconciling structure and function in the nuclear pore complex
Lim, R. Y. H., Aebi, U., & Fahrenkrog, B. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-007-0371-x · Cited by 122
Multidrug Resistance: Can New Drugs Help Chemotherapy Score Against Cancer?
Goldman, B. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.4.255 · Cited by 118
Adenomatous polyposis coli (APC) plays multiple roles in the intestinal and colorectal epithelia
Senda, T., Iizuka‐Kogo, A., Onouchi, T., & Shimomura, A. (2007) · Medical Molecular Morphology · doi:10.1007/s00795-006-0352-5 · Cited by 108
Min, Y. H., Cheong, J., Kim, J. Y., Eom, J.-I., Lee, S., Hahn, J. S., Ko, Y. W., & Lee, M. H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0174 · Cited by 107
A masked NES in INI1/hSNF5 mediates hCRM1‐dependent nuclear export: implications for tumorigenesis
Craig, E., Zhang, Z., Davies, K. P., & Kalpana, G. V. (2002) · The EMBO Journal · doi:10.1093/emboj/21.1.31 · Cited by 104
Foster, J. S., Fernando, R. I., Ishida, N., Nakayama, K. I., & Wimalasena, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302830200 · Cited by 103
Durant, S. T., Morris, M. M., Illand, M., McKay, H. J., McCormick, C., Hirst, G. L., Borts, R. H., & Brown, R. E. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80047-5 · Cited by 100
Bourguignon, L., Peyrollier, K., Gilad, E., & Brightman, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604672200 · Cited by 100
Structural basis for assembly and disassembly of the CRM1 nuclear export complex
Dong, X., Biswas, A., & Chook, Y. M. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1586 · Cited by 97
Nucleo-Cytoplasmic Transport of Proteins as a Target for Therapeutic Drugs
Yashiroda, Y., & Yoshida, M. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457791 · Cited by 95
Nucleocytoplasmic Protein Transport and Recycling of Ran.
Yoneda, Y., Hieda, M., Nagoshi, E., et al. (1999) · Cell Structure and Function · doi:10.1247/csf.24.425 · Cited by 92
The tumor microenvironment: focus on myeloma
Dalton, W. J. (2003) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(03)00077-x · Cited by 91
The Nuclear Pore Complex: Oily Spaghetti or Gummy Bear?
Weis, K. (2007) · Cell · doi:10.1016/j.cell.2007.07.029 · Cited by 87
Shin, I., Rotty, J. D., Wu, F. Y., & Arteaga, C. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412367200 · Cited by 87
Ratjadones inhibit nuclear export by blocking CRM1/exportin 1
Köster, M., Lykke‐Andersen, S., Elnakady, Y. A., Gerth, K., Washausen, P., Höfle, G., Sasse, F., Kjems, J., & Häuser, H. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00100-9 · Cited by 85
The role of the 3D environment in hypoxia-induced drug and apoptosis resistance.
Kim, J. W., Ho, W. J., & Wu, B. M. (2011) · PubMed · Cited by 83
Human Multiple Myeloma Cells Are Sensitized to Topoisomerase II Inhibitors by CRM1 Inhibition
Turner, J. G., Marchion, D. C., Dawson, J. L., Emmons, M. F., Hazlehurst, L., Washausen, P., & Sullivan, D. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0484 · Cited by 81
Self-citationRatjadone and leptomycin B block CRM1‐dependent nuclear export by identical mechanisms
Meissner, T. B., Krause, E., & Vinkemeier, U. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.08.056 · Cited by 79
Localization of G-protein-coupled receptors in health and disease
Edwards, S. W., Tan, C. M., & Limbird, L. E. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01513-3 · Cited by 78
Acute myeloid leukemia with mutated nucleophosmin (NPM1): Any hope for a targeted therapy?
Falini, B., Gionfriddo, I., Cecchetti, F., Ballanti, S., Pettirossi, V., & Martelli, M. P. (2011) · Blood Reviews · doi:10.1016/j.blre.2011.06.001 · Cited by 76
Wang, W.-S., Zhong, H., Xiao, D., Huang, X., Liao, L., Xie, Z., Xu, X., Shen, Z., Xu, L., & Li, E. (2010) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2009.01035.x · Cited by 73
Nxt1 Is Necessary for the Terminal Step of Crm1-Mediated Nuclear Export
Black, B. E., Holaska, J. M., Lévesque, L., Ossareh‐Nazari, B., Gwizdek, C., Dargemont, C., & Paschal, B. M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.1.141 · Cited by 70
Danks, M. K., Garrett, K. E., Marion, R. C., & Whipple, D. O. (1996) · PubMed · Cited by 69
Nuclear transport as a target for cell growth
Kau, T. R., & Silver, P. A. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02562-x · Cited by 69
Kinetic and Molecular Analysis of Nuclear Export Factor CRM1 Association with Its Cargo In Vivo
Daelemans, D., Costes, S. V., Lockett, S., & Pavlakis, G. N. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.2.728-739.2005 · Cited by 69
New Rev-transport inhibitor with anti-HIV activity from Valerianae Radix
Murakami, N., Ye, Y., Kawanishi, M., Aoki, S., Kudo, N. R., Yoshida, M., Nakayama, E. E., Shioda, T., & Kobayashi, M. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00624-8 · Cited by 69
Jiao, W., Datta, J., Lin, H., Dundr, M., & Rane, S. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605271200 · Cited by 67
Cell cycle-dependent nucleocytoplasmic shuttling of the neurofibromatosis 2 tumour suppressor merlin
Muranen, T. E., Grönholm, M., Renkema, G. H., & Carpén, O. (2004) · Oncogene · doi:10.1038/sj.onc.1208283 · Cited by 66
Controlling Protein Compartmentalization to Overcome Disease
Davis, J. R., Kakar, M., & Lim, C. S. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9133-z · Cited by 65
Oloumi, A., MacPhail, S. H., Johnston, P. J., Banáth, J. P., & Olive, P. L. (2000) · PubMed · Cited by 59
The Cytoplasmic Domain of Vamp4 and Vamp5 Is Responsible for Their Correct Subcellular Targeting
Zeng, Q., Tran, T. T. H., Tan, H.-X., & Hong, W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303214200 · Cited by 58
Aloisi, A., Gregorio, S. D., Stagno, F., Guglielmo, P., Mannino, F., Sormani, M. P., Bruzzi, P., Gambacorti-Passerini, C. B., Saglio, G. N., Venuta, S., et al. (2005) · Blood · doi:10.1182/blood-2005-05-2123 · Cited by 57
Nuclear translocation of the pro-apoptotic Bcl-2 family member Bok induces apoptosis
Bartholomeusz, G. A., Wu, Y., Ali‐Seyed, M., Xia, W., Kwong, K. Y., Hortobágyi, G. N., & Hung, M. (2005) · Molecular Carcinogenesis · doi:10.1002/mc.20156 · Cited by 45
Rodríguez-Vilarrupla, A., Jaumot, M., Abella, N., Canela-Canela, N., Brun, S., Díaz, C., Estanyol, J. M., Bachs, O., & Agell, N. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.16.7364-7374.2005 · Cited by 44
Cell proliferation regulated by estradiol receptor: Therapeutic implications
Castoria, G., Migliaccio, A., Giovannelli, P., & Auricchio, F. (2009) · Steroids · doi:10.1016/j.steroids.2009.10.007 · Cited by 41
TOB suppresses breast cancer tumorigenesis
O’Malley, S. M., Su, H., Zhang, T., Ng, C., Ge, H., & Tang, C. K. (2009) · International Journal of Cancer · doi:10.1002/ijc.24490 · Cited by 41
Keeshan, K., Cotter, T. G., & McKenna, S. L. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04538.x · Cited by 38
Cytoplasmic localization and ubiquitination of p21Cip1 by reactive oxygen species
Hwang, C. Y., Kim, I. Y., & Kwon, K. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.120 · Cited by 34
Nakamura, T., Imai, H., Tsunashima, N., & Nakagawa, Y. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.183 · Cited by 25
Maekawa, M., Yamamoto, T., & Nishida, E. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.12.016 · Cited by 21
LI, X., HALUSKA, P., HSIANG, Y., BHARTI, A., KUFE, D. W., & RUBIN, E. H. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb26381.x · Cited by 21
Mapping nucleolar localization sequences of 1A6/DRIM
Liu, J., Du, X., & Ke, Y. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.01.064 · Cited by 18
Multi parameter in vitro testing of ratjadone using flow cytometry
Burzlaff, A., Kalesse, M., Kasper, C., et al. (2003) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-003-1300-0 · Cited by 18
Kumari, G., & Mahalingam, S. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.06.013 · Cited by 14
Castoria, G., Migliaccio, A., & Auricchio, F. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.01.006 · Cited by 14
Cited by
The mechanism of HMGB1 secretion and release
Chen, R., Kang, R., & Tang, D. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00736-w · Cited by 849
Genomic and molecular characterization of esophageal squamous cell carcinoma
Lin, D.-C., Hao, J.-J., Nagata, Y., Xu, L., Shang, L., Meng, X., Sato, Y., Okuno, Y., Varela, A. M., Ding, L.-W., et al. (2014) · Nature Genetics · doi:10.1038/ng.2935 · Cited by 626
Zhou, J., Jiang, Y., Chen, H., Wu, Y., & Zhang, L. (2020) · Cell Proliferation · doi:10.1111/cpr.12739 · Cited by 322
RetractedTai, Y.-T., Landesman, Y., Acharya, C., Calle, Y., Zhong, M. Y., Cea, M., Tannenbaum, D., Cagnetta, A., Reagan, M., Munshi, A. A., et al. (2014) · Leukemia · doi:10.1038/leu.2013.115 · Cited by 308
Lapalombella, R., Sun, Q., Williams, K., Tangeman, L., Jha, S., Zhong, Y., Goettl, V., Mahoney, E., Berglund, C., Gupta, S., et al. (2012) · Blood · doi:10.1182/blood-2012-05-429506 · Cited by 302
Metadata
- Authors
- Turner, J. G., Dawson, J., & Sullivan, D. M.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 83
- Issue
- 8
- Pages
- 1021-1032
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2082739624
- Cited by
- 350
- References
- 138
- FWCI
- 11.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.